Approved Cancer Medication Reduced Epileptic Seizures in Animal Models
An approved cancer medication was able to reduce average daily seizures by 60 percent in zebrafish and mice with epilepsy. That finding was in an article, “A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target,” that was…